All News

The new product is therapeutically equivalent to Pfizer’s Quelicin.

Pharmacists' No. 1 picks include DayQuil Cold & Flu and Children's Tylenol.

The COVID-19 pandemic rapidly pushed traditional face-to-face instruction within schools of pharmacy into a fully remote learning environment.

Mitapivat is an investigational, oral, small molecule allosteric activator of wild-type and a variety of mutated PKR enzymes that is not yet approved by the FDA.

Substituting calories with high quality carbohydrates, such as those in whole grains, could reduce risk of developing type 2 diabetes

The EUAs are in place for the duration of the coronavirus disease 2019 (COVID-19) pandemic.

According to a recent study, people with a higher risk of cardiovascular disease demonstrate an increase in cognitive decline, including a rise in the typical markers of Alzheimer disease.

New treatment options offer hopes of better clinical outcomes for patients suffering from Parkinson disease and its debilitating daily symptoms.

With the evolution and growth of specialty pharmacies, so too did services provided by hubs and the places where they were situated.

Closing these gaps in care could improve access for those worse affected by HIV in developing countries.

Further, although the transmission of influenza and COVID-19 are similar, the incubation period is differentiated, with a range of 1 to 4 days for influenza and a range of 2 to 12 days for COVID-19.

Technology has enhanced our ability to detect many types of medication errors, but human errors, especially those involving calculations, continue to be a problem.

Why is a patient prescribed an eye drop to be instilled in her mouth?

Dihydroergotamine Mesylate Nasal Spray is FDA-approved as therapeutic equivalent to Migranal.

IVLBCL is a rare subtype of lymphoma that is particularly hard to diagnose due to a lack of swelling or enlargement of the lymph nodes.

Investigators found that less than a quarter of study participants with colorectal cancer were taking their medications as prescribed, suggesting that many could benefit from improved adherence.

There has been more attention been paid to the pulmonary complications of COVID-19, with less attention being paid to the cardiovascular complications that can result in death or impairment.

Critical care drug products are being introduced in the United States to help ease shortages due to the COVID-19 pandemic.

The coronavirus disease 2019 (COVID-19) pandemic has caused a disruption in daily routines, including shifts in work and home life and uncertainty for the near future.

The combination of imipenem-cilastatin and relebactam was previously approved by the FDA to treat patients with complicated urinary tract infections and complicated intra-abdominal infections who have limited or no alternative treatment options.

Studies pertaining to polypharmacy have been increasing over the last decade—yet, interventions aimed to prevent and manage polypharmacy are limited.

Today, we’re celebrating Dennis Heuer, PharmD, director of pharmacy at IV Solutions LLC in Wood Dale, Illinois.

What is the best-selling drug of all time?

Flip the Pharmacy helps pharmacy teams provide enhanced clinical services for their patients and has developed a COVID-19 best practices program.

Top news of the week from Pharmacy Times®.

According to a recent study, olanzapine may help patients with advanced cancer manage symptoms unrelated to chemotherapy, such as nausea and vomiting.

Specialty pharmacy is beginning to implement its own set of strategies in order to manage the cost of one of the most expensive sectors of the pharmaceutical industry.

What characteristics of RA treatments possibly connect to COVID-19 treatment?